Core Viewpoint - Tianmu Pharmaceutical (600671) has received approval for multiple drug re-registrations from the Anhui Provincial Drug Administration, which is expected to positively impact the company's production, sales, and promotion efforts [1] Group 1: Drug Approvals - The approved drugs include: - Bu Shen Qiang Shen Pian (补肾强身片) - Chuan Xin Lian Jiao Nang (穿心莲胶囊) - Gan Mao Qing Pian (感冒清片) - Gan Mao Tui Re Ke Li (感冒退热颗粒) - Hou Tou Jun Pian (猴头菌片) - Jin Gu Cao Pian (筋骨草片) - Ling Qiao Jie Du Pian (羚翘解毒片) - Ling Yang Gan Mao Pian (羚羊感冒片) - Nao De Sheng Pian (脑得生片) - Sang Ju Gan Mao Pian (桑菊感冒片) - Shou Wu Yan Shou Pian (首乌延寿片) - Yang Xue An Shen Pian (养血安神片) [1] Group 2: Approval Validity and Application - The approval notification is valid until 2030 and is applicable for conditions such as lower back pain, dizziness, and tinnitus [1]